The significantly higher mutational frequencies of TP53, MYC, FAT4, PBRM1, PREX2were observed in BC PD‐L1‐H cohort compared with that in PD‐L1‐L and PD‐L1‐negative cohort. This evidence concerns the gene CD274 and breast cancer.